A Conversation with Baxter Japan Representative Director Glen Argyle

Joint event with ACCJ Independent Business Committee! Limited to 10 seats.

What does it take to build a clinical research startup as a foreign entrepreneur in Japan’s competitive, highly regulated pharmaceutical industry? What is it like working as the first non-Japanese hire at a traditional Japanese pharmaceutical company? How do you build a clinical research operation in a company in Japan? What does the future hold for non-Japanese pharmaceutical businesses in Japan?

If you would like to know the answers to these questions and more, come join us and ask Baxter Japan Representative Director Glen Argyle yourself.

Steven Bleistein, CEO, Relansa, Inc. will begin the conversation and leave ample time for audience members to ask their own questions. No slides. No speeches. No presentations. Just fascinating and provocative conversation.

NOTE 1: This event is OFF THE RECORD.

NOTE 2: If you are driving to Tokyo American Club, please inform the CCIFJ of the make, model, color, and plate of the vehicle by the registration deadline, as arrangements must be made. A ¥2,500 parking fee will apply.

contact: reservation(@)ccifj.or.jp

Intervenant(s)

Glen ARGYLERepresentative director

Modalités d'accès